Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02

Url canonique :
Url courte ou permalien :

Genes and cardiovascular function, 2011

Langue : Anglais

Coordonnateurs : Ostadal Bohuslav, Nagano Makoto, Dhalla Naranjan S.

Couverture de l’ouvrage Genes and cardiovascular function
Rapid advances in molecular medicine have led to pronounced new developments in experimental and clinical cardiology.  In the embrace of modern molecular biology and bridging the gap between the clinical and the genomic, cardiovascular medicine has seen major strides in the understanding of the molecular mechanisms that drive disease progression.  The ability to rapidly identify candidate human genes for cardiovascular diseases lends itself to the development of diverse strategies for disease treatment and management.  The wide variety of gene expressions proffers excellent targets for novel therapeutics.  Gene therapy is steadily increasing in viability and represents a fascinating arena of research and clinical focus. This book is based on two international Mendel symposia on 'Genes and the Heart,' joint meetings of the Japanese and European sections of the International Academy of Cardiovascular Sciences.  Highlighting selected symposia contributions, this book explores the role of molecular biology and genetics in the basic knowledge, genesis, and clinical interventions of cardiovascular diseases.

A. Genes and the Heart


1.  Johann Gregor Mendel “Father of modern genetics”

     P. Braveny


2.  Gene therapy: hopes and problems

     V. Vonka


B. Development and Gender


3.  VEGFs, FGFs and PDGF coordinate embryonic coronary vascularization

     R.J. Tomanek, L.P. Christensen


4.  The E2F pathway in cardiac development and disease

     J. Rueger, B.S. Tuana


5.  Cardiac sodium-calcium exchanger expression

     C. Hurtado, T.G. Maddaford, G.N. Pierce


6.  Scleraxis: a new regulator of extracellular matrix formation

     R.A. Bagchi, M.P. Czubryt


7.  Gender impact on pathophysiology of the heart

     J-L. Samuel, C. Delcayre, B. Swynghedauw


C. Mitochondrial Diseases


8.  Mitochondrial DNA and heart disease

     C. Shikata, M. Nemoto, T. Ebisawa, A. Nishiyama, N. Takeda


9.  A novel algorithm from personal genome to the pathogenic mutant causing      mitochondrial cardiomyopathy

     T. Toyo-oka, T. Tanaka, L. Toyo-oka, K. Tokunaga


10. MELAS Syndrome: mediated by impaired taurinomethyluridine synthesis

      S. Schaffer, C. Ju Jong


D. Ischemic Heart Disease


11. Genetics of myocardial infarction

      R. Poledne, J.A. Hubacek


12. Genetic background of myocardial infarction

      K. Ozaki, T. Tanaka


13. I/D ACE polymorphism and cardiovascular risk: disclosed story

      A. Vasku, J. Blahak, D. Baumgartner, J. B. Vasku


14. PPARs and myocardial response to ischemia in normal and diseased heart

T. Ravingerova, A. Adameova, S. Carnicka, T. Kelly, M. Nemcekova, J. Matejikova,

 A. Lazou


15. Genes and plasma lipids in Czech Slavic population

      J.A. Hubacek, R. Poledne


E. Hypertension and Arrhythmias


16. Genetic basis of salt-sensitive hypertension in humans

       F.H.H Leenen, Md.S. Amin, A.F.R. Stewart, F. Tesson


17. Gene-environment interactions: their role in hypertension development

      J. Kunes, M. Kadlecova, J. Zicha


18. Phenotypic overlap of lethal arrhythmias associated with cardiac sodium mutations: Individual-specific or mutation-specific?

       N. Makita


F. Hypertrophy and Failure


19. CLP-1 mediated transcriptional control of hypertrophic gene programs underlying cardiac hypertrophy

       M.A.Q. Siddiqui, M. Wagner, J. Espinoza-Derout, F. Huang, D. Beckles, E. Mascareno


20. Molecular mechanisms of subcellular remodeling in congestive heart failure

       A.P. Babick, A.L. Müller, N.S. Dhalla


21. Cardiomyopathy, sarcomeropathy and Z-discopathy

       A. Kimura


22. Left ventricular assist device: morphological, molecular and genetic changes after  mechanical support

       H.A. Baba, A. Takeda, N. Takeda, J. Wohlschlaeger


23. Vascular Ehlers-Danlos syndrome: a good experimental model is needed for development of treatment strategies

       W. Briest, M.I. Talan


24. Multi-scale, multi-physics heart simulator as a tool to link bench and bedside

      S. Sugiura, T. Washio, J. Okada, H. Watanabe, T. Hisada

Bridges the gap between clinical cardiology and genomic study


Explores the role of genes in cardiac development


Provides a genomic approach to the treatment of the wide spectrum of cardiovascular diseases


Written by established investigators, representing the world’s leading experts in the field

Date de parution :

Ouvrage de 264 p.

17.8x25.4 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

Prix indicatif 179,34 €

Ajouter au panier

Date de parution :

17.8x25.4 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

Prix indicatif 179,34 €

Ajouter au panier

Thèmes de Genes and cardiovascular function :

En continuant à naviguer, vous autorisez Lavoisier à déposer des cookies à des fins de mesure d'audience. Pour en savoir plus et paramétrer les cookies, rendez-vous sur la page Confidentialité & Sécurité.